688314 康拓医疗
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)14.58714.45913.35914.46321.829
总资产报酬率 ROA (%)11.91812.42411.49312.49418.876
投入资产回报率 ROIC (%)12.89713.39812.37813.49120.377

边际利润分析
销售毛利率 (%)78.68879.97881.18381.47382.620
营业利润率 (%)31.54632.83633.24535.97940.614
息税前利润/营业总收入 (%)32.98432.13732.12235.25544.021
净利润/营业总收入 (%)27.84227.22127.07930.90638.195

收益指标分析
经营活动净收益/利润总额(%)107.189104.831105.57896.51186.656
价值变动净收益/利润总额(%)-7.971-11.877-2.0323.9042.262
营业外收支净额/利润总额(%)4.1290.2730.3492.4119.506

偿债能力分析
流动比率 (X)4.2204.4505.3534.6146.110
速动比率 (X)3.9094.1864.9094.1715.486
资产负债率 (%)20.36214.63813.35915.12612.554
带息债务/全部投入资本 (%)9.3515.3725.3746.1453.732
股东权益/带息债务 (%)910.8391,720.0201,729.7301,502.6422,527.007
股东权益/负债合计 (%)387.728581.101650.424562.775699.209
利息保障倍数 (X)414.795-40.744-25.925-21.854-51.197

营运能力分析
应收账款周转天数 (天)12.2318.51712.69011.9228.370
存货周转天数 (天)138.010167.884258.141312.673364.201